C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris

European Heart Journal

Volumn 21, Issue 12, 2000, Pages 1000-1008

  Tataru, M C ^a   Heinrich, J ^b   Junker, R ^a   Schulte, H ^a   Von Eckardstein, A ^a   Assmann, G ^a   Koehler, E ^c  

^a Herz und Gefäßklinik ^*

^b Pathologisches Institut   (Germany)

^c Klinikum Meiningen   (Germany)

Author keywords

Atherosclerosis; C reactive protein; Coronary disease; Myocardial infarction; Risk factors

Indexed keywords

C REACTIVE PROTEIN; D DIMER; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL AORTA; ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BRAIN ARTERY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEART INFARCTION; HUMAN; LABORATORY TEST; LEG ARTERY; MAJOR CLINICAL STUDY; MALE; PELVIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; ANGINA PECTORIS; ARTERIOSCLEROSIS; C-REACTIVE PROTEIN; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OSMOLAR CONCENTRATION; RISK FACTORS;

EID: 0034028504     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1999.1981     Document Type: Article

References (40)

1. DeJong SC, Stehouwer CD, van den Berg M, Vischer UM, Rauwerda JA, Emeis JJ. Endothelial marker proteins in hyperhomocysteinemia. Thromb Haemost. 78:1997;1332-1337.
2. Eur Heart J. 14:1993;8-17.
3. Futterman LG, Lemberg L. Inflammation in plaque rupture: an active participant or an invited guest? Am J Crit Care. 7:1998;153-161.
4. Berk BC, Weintraub WS, Alexander RW. Elevation of C-reactive protein in 'active' coronary artery disease. Am J Cardiol. 65:1990;168-172.
5. Biasucci LM, Vitelli A, Liuzzo G. Elevated levels of interleukin-6 in unstable angina. Circulation. 94:1996;874-877.
6. Biasucci LM, Liuzzo G, Caligiuri G. Episodic activation of the coagulation system in unstable angina does not elicit an acute phase reaction. Am J Cardiol. 77:1996;85-87.
7. Ikeda U, Ohkawa F, Seino Y. Serum interleukin 6 levels become elevated in acute myocardial infarction. J Mol Cell Cardiol. 24:1992;579-584.
8. Sturk A, Hack CE, Aarden LA, Brouwer M, Koster RRW, Sanders GTB. Interlukin-6 release and the acute-phase reaction in patients with acute myocardial infarction: a pilot study. J Lab Clin Med. 119:1992;574-579.
9. Mendall M, Carrington D, Strachan D. Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease. J Infect. 30:1995;121-128.
10. Mendall M, Goggin P, Levy J, Molineaux N, Strachan D. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J. 71:1994;437-439.
11. Patel P, Mendall MA, Carrington D. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ. 311:1995;711-714.
12. Thom DH, Grayston JT, Siscovick DS, Wang SP, Weiss NS, Daling JR. Association of prior infection with Chlamydia pneumoniae angiographically demonstrated coronary heart disease. JAMA. 268:1992;68-72.
13. Thompson SG, Kienast SG, Pyke SDM, Haverkate F, van de Loo JCW. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med. 332:1995;635-641.
14. Kuller LH, Tracy P, Shaten J, Meilahn EN. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case control study. Am J Epidemiol. 144:1996;537-547.
15. Ridker PM, Cushman MJ, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men. N Engl J Med. 336:1997;973-979.
16. Widder B. Doppler- und Duplex-Sonographie der hirnversorgenden Arterien. 1991;Springer, Berlin, Heidelberg, New York.
17. Kriessmann A, Bollinger A, Keller HM. Praxis der Doppler-Sonographie. 1990;Thieme, Stuttgart.
18. Lüning M, Felix R. Komplexe bildgebende Diagnostik Abdomen. 1989;Thieme, Leipzig.
19. Simon HJ, Schoop W. Diagnostik in der Kardiologie und Angiologie. 1986;Thieme, Stuttgart.
20. Kaltenbach M. Vom Belastungs-EKG zur Koronarangiographie. 1980;Springer, Berlin, Heidelberg, New York.
21. Schamroth L. EKG bei koronarer Herzkrankheit. 1988;Thieme, Stuttgart.
22. Lichtlen PR. Koronarangiographie. 1990;Perimed, Erlangen.
23. Heinrich J, Schulte H, Schönfeld R, Köhler E, Assmann G. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain. Thromb Haemost. 73:1995;374-379.
24. Nie NH, Hull CH, Jenkins JG. Statistical package for the social sciences (SPSS). 1975;McGraw-Hill, New York.
25. Haverkate F, Thompson SG, Duckert F. Haemostasis factors in angina pectoris: relation to gender, age and acute-phase reaction. Thromb Haemost. 73:1995;561-567.
26. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ. 312:1996;1061-1065.
27. Mori T, Sasaki J, Kawaguchi H. Serum glycoproteins and severity of coronary atherosclerosis. Am Heart J. 129:1995;234-238.
28. Crook M, Haq M, Haq S, Tutt P. Plasma sialic acid and acute-phase proteins in patients with myocardial infarction. Angiology. 45:1994;709-715.
29. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leucocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA. 279:1998;1477-1482.
30. Pietilä K, Harmoinen A, Pöyhönen L, Koskinen M, Heikkila J, Ruosteenoja R. Intravenous streptokinase treatment and serum C-reactive protein in patients with acute myocardial infarction. Br Heart J. 58:1987;225-229.
31. MBewu AD, Durrington PN, Bulleid S, Mackness MI. The immediate effect of streptokinase on serum lipoprotein(a) concentration and the effect of myocardial infarction on serum lipoprotein(a), apolipoproteins A1 and B, lipids and C-reactive protein. Atherosclerosis. 103:1993;65-71.
32. Andreotti F, Hackett DR, Haider AW. Von Willibrandt Factor, plasminogen activator inhibitor-1 and C-reactive protein are markers of thrombolytic efficacy in acute myocardial infarction. Thromb Haemost. 68:1992;678-682.
33. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation. 97:1998;425-428.
34. Cermak J, Key NS, Bach RR, Balla J, Jacob HS, Vercellotti GM. C-reactive protein induces human peripheral blood monocytes to synthesise tissue factor. Blood. 82:1993;513-520.
35. Ott I, Neumann FJ, Kenngott S, Gawaz M, Schomig A. Procoagulant inflammatory responses of monocytes after direct balloon angioplasty in acute myocardial infarction. Am J Cardiol. 82:1998;938-942.
36. Wolbink GJ, Brouwer MC, Buysmann S, ten Berge IJ, Hack CE. CRP-mediated activation of complement in vivo: assessment by measuring circulating complement-C-reactive protein complexes. J Immunol. 157:1996;473-479.
37. Torzewski J, Torzewski M, Bowyer DE. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions on human coronary arteries. Arterioscler Thromb Vasc Biol. 18:1998;1386-1392.
38. Reynolds GD, Vance RP. C-reactive Protein immunohistochemical localisation in normal and atherosclerotic human aorta. Arch Pathol Lab Med. 111:1987;265-269.
39. Ridker PM, Cushman MJ, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation. 97:1998;425-428.
40. Wu KK. Hemostatic tests in the prediction of atherothrombotic disease. Int J Clin Lab Res. 27:1997;145-152.